These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2677227)

  • 1. Immunogenicity of highly purified porcine and human insulins in diabetic patients with high titers of insulin antibody.
    Lam HC; Ho LT; Tang KT; Wang LM; Kwok CF; Liu YF; Hsiao LJ; Li SH
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):346-51. PubMed ID: 2677227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A twelve month double-blind randomized study of the efficacy and immunogenicity of human and porcine insulins in non-insulin-dependent diabetics.
    HO LT; Lam HC; Wu MS; Kwok CF; Jap TS; Tang KT; Wang LM; Liu YF
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):313-9. PubMed ID: 1649672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of monocomponent human and porcine insulin in non-insulin dependent diabetes mellitus.
    Lam HC; Tang KT; Wang JT; Liu YF; Wang LM; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Mar; 41(3):217-22. PubMed ID: 3052740
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of highly purified bovine insulin: a comparison with conventional bovine and highly purified human insulins.
    Wilson RM; Douglas CA; Tattersall RB; Reeves WG
    Diabetologia; 1985 Sep; 28(9):667-70. PubMed ID: 3905477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control.
    Peacock I; Tattersall RB; Taylor A; Douglas CA; Reeves WG
    Lancet; 1983 Jan; 1(8317):149-52. PubMed ID: 6130198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects.
    Larkins RG; Zajac J; Saunders R; Read A; Hopper JL
    Aust N Z J Med; 1986 Apr; 16(2):206-10. PubMed ID: 3530226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production.
    Mann NP; Johnston DI; Reeves WG; Murphy MA
    Br Med J (Clin Res Ed); 1983 Nov; 287(6405):1580-2. PubMed ID: 6416511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic children.
    Bistritzer T; Sack J; Theodor R; Weissglass L; Ben-Bassat I; Lahav M
    Horm Res; 1984; 20(3):178-85. PubMed ID: 6386647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind crossover trial comparing human insulin (recombinant DNA) with animal insulins in the treatment of previously insulin-treated diabetic patients.
    Clark AJ; Wiles PG; Leiper JM; Knight G; Adeniyl-Jones RO; Watkins PJ; Ward JD; MacCuish AC; Keen H; Jones RH
    Diabetes Care; 1982; 5 Suppl 2():129-34. PubMed ID: 6765523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.
    Gardner DF; Wilson HK; Podet EJ; Arakaki RF; Nell LJ; Thomas JW; Crane MM; Field JB
    J Clin Endocrinol Metab; 1986 Apr; 62(4):621-7. PubMed ID: 3512590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative multicenter study of bovine insulin with forms more purified of swine and human insulin in the treatment of type 1 diabetes mellitus].
    Russo EM; Wajchenberg BL; Romaldini JH; Liberman B; Gross JL; Reis LC
    AMB Rev Assoc Med Bras; 1991; 37(2):73-8. PubMed ID: 1658875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.
    Gray RS; Borsey DQ; Fraser DM; Kurtz AB; Rainbow S; Smith AF; Duncan LJ; Clarke BF
    Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of human and bovine insulin in type 1 diabetes mellitus patients.
    Himanshu M; Bhat CB; Ramchandran S; Bhat KG; Kumar PK
    Diabetes Technol Ther; 2008 Aug; 10(4):305-9. PubMed ID: 18715205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of complement activation and consumption in diabetic children and adolescents after switch-over from porcine to semisynthetic human insulin.
    Dorchy H; Duchateau J; D'Hooge D
    Diabete Metab; 1988; 14(4):415-21. PubMed ID: 3066649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of transfer from animal-source insulins to biosynthetic human insulin (rDNA E coli) in patients with diabetes mellitus.
    Garber AJ; Davidson JA; Krosnick A; Beaser RS; Anderson JH
    Clin Ther; 1991; 13(5):627-36. PubMed ID: 1799920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of recombinant DNA human insulin.
    Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ; Hufferd S
    Diabetologia; 1983 Dec; 25(6):465-9. PubMed ID: 6198228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.